An independent advisory committee to the Centers for Disease Control and Prevention (CDC) met on Wednesday to discuss the recommended pause in administering the Johnson & Johnson vaccine after six people developed severe blood clots.
After a four-hour discussion, the Advisory Committee on Immunization Practices (ACIP) agreed that more time was necessary to review data and potential health risks prior to voting on a recommendation. Members of the committee said they required more information before changing any recommendations.
A vote would not happen for at least another seven to 10 days until the panel reconvened again.
The CDC convened an emergency meeting of its ACIP after it announced alongside the Food and Drug Administration (FDA) on Tuesday that the federal agencies recommended for states to pause administering the Johnson & Johnson vaccine.
More than 7 million single-dose vaccines were administered to Americans, but the FDA was now investigating six cases where women ages 18 to 48 developed severe blood clots following inoculation. Symptoms such as severe headache and abdominal pain started for the women six to 13 days after receiving the vaccine.
One woman died after she developed the blood clots and another was in critical condition, health officials said.
The announcement from the federal health agencies encouraged all 50 states, Washington DC, and Puerto Rico to halt using the Johnson & Johnson vaccine until a new recommendation was reached between experts.
More follows ...